PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mayo Clinic discovery selected for Science's Top 10 Achievements of 2011

2011-12-23
(Press-News.org) ROCHESTER, Minn. -- The editors of the journal Science have selected a Mayo Clinic discovery as one of their top 10 "groundbreaking scientific achievements of 2011." The Mayo study --the first to eliminate the effects of aging in mice -- received worldwide attention when it was published in Nature in November. Science's international list of achievements featuring scientific breakthroughs ranging from biology to aerospace research was released Thursday afternoon.

The study showed that the onset of age-related disorders and disabilities could be delayed or prevented by eliminating senescent cells: cells that have become "deadbeat" and are no longer dividing.

"This is indeed an honor, coming from Science in particular," says Jan van Deursen, Ph.D., a Mayo Clinic molecular biologist and senior author of the study. "We're pleased for this recognition for our team and collaborators, including the Mayo Clinic Robert and Arlene Kogod Center on Aging."

The Science editors expressed enthusiasm that "mice whose bodies were cleared of these loitering cells didn't live longer than their untreated cage-mates -- but they did seem to live better, which provided researchers with some hope that banishing senescent cells might also prolong our golden years."

"Our discovery demonstrates that, in our body, cells are accumulating that cause these age-related disorders and discomforts," says Dr. van Deursen, the Vita Valley Professor of Cellular Senescence at Mayo Clinic. "Therapeutic interventions to get rid of senescent cells or block their effects may represent an avenue to make us feel more vital, healthier, and allow us to stay independent for a much longer time."

The research is an important step in the quest to improve health-span -- not necessarily living a longer life, but a healthier, more productive one.

###Co-authors of the article are Darren Baker, Ph.D., Tamar Tchkonia, Ph.D., Nathan LeBrasseur, Ph.D., James Kirkland, M.D., Ph.D., and Bennett Childs, all of Mayo Clinic; and Tobias Wijshake and Bart van de Sluis, Ph.D., both of Groningen University, the Netherlands. The Ellison Medical Foundation, the Noaber Foundation, the Mayo Clinic Robert and Arlene Kogod Center on Aging and the National Institutes of Health funded the study.

About Mayo Clinic Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.org/about/ and http://www.mayoclinic.org/news.


ELSE PRESS RELEASES FROM THIS DATE:

Uninsured and Underinsured Motorists Leave Accident Victims Few Options

2011-12-23
In every state but New Hampshire, drivers are required by law to carry liability insurance or some other proof of financial responsibility. This coverage ensures that those injured in motor vehicle accidents have resources available to compensate them for medical bills, wages lost due to an inability to work and other losses arising out of a crash. Adequate insurance coverage also protects those who carry it, even if they are not injured: drivers who cause an accident but lack coverage must pay out of pocket to compensate victims. Yet, according to an Insurance Research ...

Drugs used to overcome cancer may also combat antibiotic resistance: McMaster researchers

2011-12-23
Hamilton, ON (Dec. 22, 2011) - Drugs used to overcome cancer may also combat antibiotic resistance, finds a new study led by Gerry Wright, scientific director of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University. "Our study found that certain proteins, called kinases, that confer antibiotic resistance are structurally related to proteins important in cancer," says Wright about the study published in Chemistry & Biology. "The pharmaceutical sector has made a big investment in targeting these proteins, so there are a lot of compounds ...

Previously unconnected molecular networks conspire to promote cancer

2011-12-23
HOUSTON — An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell. Working in liver cancer cell lines, the team discovered a mechanism by which tumor necrosis factor alpha (TNFα) stimulates tumor formation, said senior author Mien-Chie Hung, Ph.D., professor and chair of MD Anderson's Department of Molecular and Cellular Oncology. Hung also is MD Anderson's ...

HIV study named 2011 breakthrough of the year by Science

2011-12-23
The journal Science has chosen the HPTN 052 clinical trial (http://www.niaid.nih.gov/news/newsreleases/2011/Pages/HPTN052.aspx), an international HIV prevention trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, as the 2011 Breakthrough of the Year. The study found that if HIV-infected heterosexual individuals begin taking antiretroviral medicines when their immune systems are relatively healthy as opposed to delaying therapy until the disease has advanced, they are 96 percent less likely to transmit ...

Enzyme that flips switch on cells' sugar cravings could be anti-cancer target

Enzyme that flips switch on cells sugar cravings could be anti-cancer target
2011-12-23
Cancer cells tend to take up more glucose than healthy cells, and researchers are increasingly interested in exploiting this tendency with drugs that target cancer cells' altered metabolism. Cancer cells' sugar cravings arise partly because they turn off their mitochondria, power sources that burn glucose efficiently, in favor of a more inefficient mode of using glucose. They benefit because the byproducts can be used as building blocks for fast-growing cells. Scientists at Winship Cancer Institute of Emory University have shown that many types of cancer cells flip ...

Project Educates Mothers to Avoid Unnecessary C-Sections

2011-12-23
Michigan hospitals are becoming the first of their kind in implementing a project that aims to avoid unnecessary C-sections. A lower rate of C-section deliveries is associated with healthier babies and a lower risk of a birth injury. The Michigan Health and Hospital Association Keystone obstetrics project implements changes to hospitals in Michigan in their birthing procedures. The project discourages elective or C-section births unless it is for medically necessary reasons such as chronic disease, a mother carrying multiple babies or the baby is small and developing ...

New technique makes it easier to etch semiconductors

New technique makes it easier to etch semiconductors
2011-12-23
CHAMPAIGN, Ill. — Creating semiconductor structures for high-end optoelectronic devices just got easier, thanks to University of Illinois researchers. The team developed a method to chemically etch patterned arrays in the semiconductor gallium arsenide, used in solar cells, lasers, light emitting diodes (LEDs), field effect transistors (FETs), capacitors and sensors. Led by electrical and computer engineering professor Xiuling Li, the researchers describe their technique in the journal Nano Letters. A semiconductor's physical properties can vary depending on its structure, ...

Promising treatments for blood cancers presented by JTCancerCenter researchers at ASH meeting

2011-12-23
HACKENSACK, N.J. (December 22, 2011) — Researchers from the John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 best hospitals for cancer, presented results from 31 major studies of blood-related cancers – leukemia, lymphoma and multiple myeloma -- during the American Society of Hematology (ASH) Annual Meeting, December 10-13, 2011 in San Diego. Research highlights from the John Theurer Cancer Center included a global clinical trial of a new type of medication (HDAC inhibitor) against relapsed multiple myeloma led at the John ...

Pitt/Children's Hospital team: Cell membrane proteins could provide targets for broader vaccines

2011-12-23
PITTSBURGH, Dec. 22 – Vaccines with broader reach might be made by stimulating specialized immune cells to recognize foreign cell membrane proteins that are shared across bacterial species, say researchers from Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine in a report published online today in Immunity. The approach could be particularly beneficial in preventing infection by multi-drug resistant organisms. The genetic heritage of organisms such as oysters, frogs and fish indicate that a family of cell-signaling molecules ...

MSU chemists become the first to solve an 84-year-old theory

2011-12-23
EAST LANSING, Mich. — The same principle that causes figure skaters to spin faster as they draw their arms into their bodies has now been used by Michigan State University researchers to understand how molecules move energy around following the absorption of light. Conservation of angular momentum is a fundamental property of nature, one that astronomers use to detect the presence of satellites circling distant planets. In 1927, it was proposed that this principle should apply to chemical reactions, but a clear demonstration has never been achieved. In the current issue ...

LAST 30 PRESS RELEASES:

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

[Press-News.org] Mayo Clinic discovery selected for Science's Top 10 Achievements of 2011